Abdominal Laparoscopic SurgeryMAESTRONCT07858929
Application of the Maestro Surgical System for Surgical Assistance in Laparoscopic Abdominal Surgery
An observational study of Abdominal Laparoscopic Surgery, run by Portsmouth Hospitals NHS Trust at 1 site in United Kingdom.
Trial summary
This study is designed to evaluate the application of the Maestro Robotic Platform for surgical assistance in laparoscopic abdominal surgery. The purpose of this study is to assess the system use in general surgery on different procedures, level of complexity, and type of setting (elective/emergency). Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Abdominal Laparoscopic Surgery
- What is being tested?
- Any abdominal laparoscopic surgery with the usage of the Maestro Platform.
- Type of treatment
- Surgery or procedure
- How many people
- 100 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 13 Mar 2026to 12 Apr 2027
- How long will I take part?
- 30 Days
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients undergoing laparoscopic abdominal surgery with the assistance of Maestro.
Who may be able to join
- The participant must meet ALL the following criteria to be considered eligible for the study:
- Aged 18 years or above
- Undergoing minimally invasive abdominal surgery
- Participant is able to give informed consent for participation in the study.
Who cannot join
- The participant may not enter the study if ANY of the following apply:
- Vulnerable populations
- Any medical, psychiatric, or occupational condition, including a history of substance abuse, that may pose additional risk or interfere with study results, as determined by the investigator
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United Kingdom1 site, 1 recruiting
- Recruiting
Portsmouth Hospitals University NHS Trust
Portsmouth
Guglielmo Niccolo Piozzi, MD, 02392286000 ext. 5153, guglielmo.piozzi@nhs.net
About this study
This study is designed to evaluate the application of the Maestro Robotic Platform for surgical assistance in laparoscopic abdominal surgery. The purpose of this study is to assess the system use in general surgery on different procedures, level of complexity, and type of setting (elective/emergency).
- Conditions
- Abdominal Laparoscopic Surgery
- Being tested
- Any abdominal laparoscopic surgery with the usage of the Maestro Platform.
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Any abdominal laparoscopic surgery with the usage of the Maestro Platform.Procedure or surgery
Any abdominal laparoscopic surgery with the usage of the Maestro Platform.
What is being measured
The primary outcome is the main question the study is designed to answer.
Intra-operative outcomes
- All adverse events (description)
Measured: Day 1
Secondary outcomes (17)
Post-operative outcomes- hospitalization
Hospitalization period (days)
Measured: Day 30
Intra-operative measures- complications
Procedure-specific complications (description)
Measured: Day 1
Post-operative outcome- pain
Post-operative pain (pain score 0-4)
Measured: Day 1
Post-operative outcomes- complications
Post-operative complications; descriptions 30 days)
Measured: Up to 30 days post-surgery
Post-operative outcomes- evaluation
Surgeon evaluation of solo-surgery possibility (description)
Measured: Day 1
Post-operative outcomes- comfort
Surgeon comfort (NASA Task Load Index ((NASA-TLX))
Measured: Day 1
Post-operative outcomes- satisfaction
Surgeon satisfaction with the assistance level from Maestro (description)
Measured: Day 1
Intra-operative measures- Device
Device-related issues (description)
Measured: Day 1
Intra-operative measures- Conversion
Conversion rate (%)
Measured: Day 1
Intra-operative measures- Time
Operating time (minutes)
Measured: Day 1
Intra-operative measures-in out time
Wheels-in to wheels-out time (HH:MM)
Measured: Day 1
Intra-operative measures- skin time
Skin to skin time (minutes)
Measured: Day 1
Intra-operative measures- turnaround
Turnaround time (minutes)
Measured: Day 1
Intra-operative measures- cleaning
Camera cleaning rate (number of cleaning per case)
Measured: Day 1
Intra-operative measures- human resource
Human resource (number of team members per case)
Measured: Day 1
Intra-operative measures- utilization
Utilization for surgical assistance in the operating room (Y/N)
Measured: Day 1
Intra-operative measures- ScoPilot
ScoPilot Use (%)
Measured: Day 1
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Oct 2026
- Study start13 Mar 2026
- Primary completion12 Mar 2027 (estimated)
- Study completion12 Apr 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Abdominal Laparoscopic SurgeryStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 100 participants (estimated)
- Target duration
- 30 Days
Sponsor and investigators
- Lead sponsor
- Portsmouth Hospitals NHS Trust
- Sponsor type
- Other government
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07858929
- Sponsor's protocol ID
- IRAS 361700
- Acronym
- MAESTRO
- Status last verified
- Sep 2026
- First submitted
- 30 Apr 2026
- Last updated
- 5 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No